On Feb. 7, MedImmune
- Revenue increased by 7.5% because of growth in the sales of Synagis.
- The company sold its CytoGam line, recognizing a gain of $49 million, and realized gains of $42 million through the sale of two investments in its venture capital investment portfolio. These one-time events drove the large increase in net income.
- In 2006, MedImmune repurchased around 11 million shares for $328 million, which was partly financed by convertible senior notes issued in June.
- The company estimated that revenue will grow by 19% this year.
(Figures in millions, except per-share data)
Income Statement Highlights
Q4 2006 |
Q4 2005 |
Change |
|
---|---|---|---|
Sales |
$528.7 |
$492.0 |
7.5% |
Net Profit |
$120.7 |
($22.4) |
N/A |
EPS |
$0.50 |
($0.09) |
N/A |
Diluted Shares |
242.5 |
246.4 |
(1.6%) |
Get back to basics with a look at the income statement.
Margin Checkup
Q4 2006 |
Q4 2005 |
Change* |
|
---|---|---|---|
Gross Margin |
74.1% |
71.5% |
2.6 |
Operating Margin |
32.8% |
(2.2%) |
35.0 |
Net Margin |
22.8% |
(4.6%) |
27.4 |
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
Assets |
Q4 2006 |
Q4 2005 |
Change |
---|---|---|---|
Cash + ST Invest. |
$1,505.2 |
$1,471.9 |
2.3% |
Accounts Rec. |
$256.6 |
$284.3 |
(9.7%) |
Inventory |
$85.3 |
$69.4 |
22.9% |
Liabilities |
Q4 2006 |
Q4 2005 |
Change |
---|---|---|---|
Accounts Payable |
$45.5 |
$37.0 |
23.0% |
Long-Term Debt |
$1,165.5 |
$506.2 |
103.2% |
Learn the ways of the balance sheet.
Cash Flow Highlights
No data was available.
Find out why Fools always follow the money.
Related companies:
-
Biogen Idec
(NASDAQ:BIIB) -
Gilead Sciences
(NASDAQ:GILD) -
Millipore
(NYSE:MIL) -
Millennium Pharmaceuticals
(NASDAQ:MLNM) -
Genzyme
(NASDAQ:GENZ)
Related Foolishness:
Biogen Idec is a Stock Advisor recommendation and Millennium is a Rule Breakers pick. Talk stocks with other investors and our analysts when you give our newsletters a try.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.